← Leaderboards
Gurmit Grewal
National Center For Advancing Translational Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Center For Advancing Translational Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Inhibitor/Antagonist”
- John M Lachin · George Washington University$117,867,649
- David M Nathan · Massachusetts Institute Of Technology$117,867,649
- Randall J Bateman · Washington University$110,978,751
- David Heimbrook · Leidos Biomedical Research, Inc.$72,139,282
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Walter John Curran · Thomas Jefferson University$32,790,605
Research focus
Inhibitor/AntagonistLinkPharmaceutical PreparationsDesignLiteratureTechnologyAmino AcidsAlkenesCyclin D1Bcl2 GeneBiologicalCancer InitiationCancer TherapyCell CycleBaseAlpha HelixCell ProliferationCell LineCellsClinicC-Myc GenesCollaborationsComputational ChemistryApoptosis
Grant awards (4)
Stabilized Helical Peptides$428,500
ZIA · FY2019 · TR · contact PI
HDAC/PI3K Dual Inhibitors for Treatment of Rare Cancers$428,500
ZIA · FY2019 · TR · contact PI
Stabilized Helical Peptides$428,500
ZIA · FY2018 · TR · contact PI
HDAC/PI3K Dual Inhibitors for Treatment of Rare Cancers$428,500
ZIA · FY2018 · TR · contact PI